These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 1347742
1. Regulation of intermediate pituitary corticotropin-releasing hormone receptors by dopamine. Shiver T, Familari M, Aguilera G. Endocrinology; 1992 Apr; 130(4):2299-304. PubMed ID: 1347742 [Abstract] [Full Text] [Related]
4. Dopamine inhibition of proopiomelanocortin gene expression in the intermediate lobe of the pituitary. Interactions with corticotropin-releasing factor and the beta-adrenergic receptors and the adenylate cyclase system. Loeffler JP, Demeneix BA, Kley NA, Höllt V. Neuroendocrinology; 1988 Feb; 47(2):95-101. PubMed ID: 2963967 [Abstract] [Full Text] [Related]
5. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Hauger RL, Aguilera G. Endocrinology; 1993 Oct; 133(4):1708-14. PubMed ID: 8404613 [Abstract] [Full Text] [Related]
8. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses. Wynn PC, Harwood JP, Catt KJ, Aguilera G. Endocrinology; 1985 Apr; 116(4):1653-9. PubMed ID: 2982594 [Abstract] [Full Text] [Related]
9. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3',5'-cyclic adenosine monophosphate, and glucocorticoids. Gagner JP, Drouin J. Mol Endocrinol; 1987 Oct; 1(10):677-82. PubMed ID: 2856398 [Abstract] [Full Text] [Related]
11. Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization. Grigoriadis DE, De Souza EB. Peptides; 1989 Oct; 10(1):179-88. PubMed ID: 2546128 [Abstract] [Full Text] [Related]
12. Dopaminergic regulation of galanin gene expression in the rat anterior pituitary gland. Hyde JF, Keller BK, Howard G. J Neuroendocrinol; 1992 Aug; 4(4):449-54. PubMed ID: 21554629 [Abstract] [Full Text] [Related]
13. D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase. Cote TE, Felder R, Kebabian JW, Sekura RD, Reisine T, Affolter HU. J Biol Chem; 1986 Apr 05; 261(10):4555-61. PubMed ID: 3957908 [Abstract] [Full Text] [Related]
14. Hypothalamic-pituitary corticotroph function after shunting of magnocellular vasopressin and oxytocin to the hypophyseal portal circulation. Makara GB, Kiss A, Lolait SJ, Aguilera G. Endocrinology; 1996 Feb 05; 137(2):580-6. PubMed ID: 8593805 [Abstract] [Full Text] [Related]
15. Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Dave JR, Eiden LE, Karanian JW, Eskay RL. Endocrinology; 1986 Jan 05; 118(1):280-6. PubMed ID: 2934242 [Abstract] [Full Text] [Related]
16. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids. Luo X, Kiss A, Rabadan-Diehl C, Aguilera G. Endocrinology; 1995 Sep 05; 136(9):3877-83. PubMed ID: 7649095 [Abstract] [Full Text] [Related]
17. Characteristics and developmental changes of corticotrophin-releasing hormone-binding sites in the fetal sheep anterior pituitary gland. Lü F, Yang K, Challis JR. J Endocrinol; 1991 Aug 05; 130(2):223-9. PubMed ID: 1655941 [Abstract] [Full Text] [Related]
18. Receptors for corticotropin-releasing hormone in human pituitary: binding characteristics and autoradiographic localization to immunocytochemically defined proopiomelanocortin cells. Smets G, Vauquelin G, Moons L, Smitz J, Klöppel G. J Clin Endocrinol Metab; 1991 Aug 05; 73(2):268-74. PubMed ID: 1649837 [Abstract] [Full Text] [Related]